Skip to main content
SpringerLink
Log in

Selective Internal Radiation Therapy

  • Chapter
Percutaneous Tumor Ablation in Medical Radiology

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 1195 Accesses

Abstract

The majority of primary and secondary malignant hepatic tumors are not suitable for surgical resection, which makes systemic chemotherapy treatments and/or local ablative therapies important components of intention-to-treat concepts or palliation. Tumor load and type of response determine the efficacy of these therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B (1994) Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35:1637–1644

    PubMed  CAS  Google Scholar 

  • Ariel IM (1964) Radioactive isotopes for adjuvant cancer therapy. Arch Surg 89:244–249

    PubMed  CAS  Google Scholar 

  • Ariel IM, Padula G (1982) Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 20:151–156

    Article  PubMed  CAS  Google Scholar 

  • Blanchard RJ, Grotenhuis I, LaFave JW (1964) Treatment of experimental tumors: utilization of radioactive microspheres. Arch Surg 89:406

    PubMed  CAS  Google Scholar 

  • Blanchard RJ, LaFave JW, Kim YS (1965) Treatment of patients with advanced cancer using Y-90 microspheres. Cancer 18:375

    Article  PubMed  CAS  Google Scholar 

  • Burton MA, Gray BN, Klemp PF, Kelleher DK, Hardy N (1989) Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol 25:1487–1491

    Article  PubMed  CAS  Google Scholar 

  • Carr B (2004) Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplant 10[2, Suppl. 1]:107–110

    Article  Google Scholar 

  • Dancey JE, Shepherd FA, Paul K et al (2000) Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 41:1673–1681

    PubMed  CAS  Google Scholar 

  • Dawson LA, McGinn CJ, Normolle D et al (2000) Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18:2210–2218

    PubMed  CAS  Google Scholar 

  • Geschwind JF, Salem R, Carr BI et al (2004) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127:S194–S205

    Article  PubMed  CAS  Google Scholar 

  • Goin JE, Salem R, Carr BI et al (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213

    PubMed  Google Scholar 

  • Gray B, Van Hazel G, Hope M et al (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711–1720

    Article  PubMed  CAS  Google Scholar 

  • Gray BN, Burton MA, Kelleher DK, Anderson J, Klemp P (1989) Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol 42:192–196

    Article  PubMed  CAS  Google Scholar 

  • Gray BN, Anderson JE, Burton MA et al (1992) Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg 62:105–110

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto K, Ikeda Y, Korenaga D et al (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103:1856–1864

    Article  PubMed  CAS  Google Scholar 

  • Herba MJ, Thirlwell MP (2002) Radioembolization for hepatic metastases. Semin Oncol 29:152–159

    Article  PubMed  Google Scholar 

  • Ho S, Lau WY, Leung TW et al (1996) Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 23:947–952

    Article  PubMed  CAS  Google Scholar 

  • Ho S, Lau WY, Leung TW et al (1997a) Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 70:823–828

    PubMed  CAS  Google Scholar 

  • Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK (1997b) Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 24:293–298

    PubMed  CAS  Google Scholar 

  • Kennedy AS, Salem R (2003) Comparison of two 90Yttrium microsphere agents for hepatic artery brachytherapy. Proceedings of the 14th International Congress on Anti-Cancer Treatment 2003, p 156

    Google Scholar 

  • Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C (2004) Pathologic response and microdosimetry of 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60:1552–1563

    Article  PubMed  CAS  Google Scholar 

  • Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA Experience. Int J Radiat Oncol Biol Phys 65:412–425

    Article  PubMed  CAS  Google Scholar 

  • Kulik LM, Mulcahy MF, Hunter RD, Nemcek AA Jr., Abecassis MM, Salem R (2005) Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. Liver Transpl 11:1127–1131

    Article  PubMed  Google Scholar 

  • Kulik LM, Atassi B, van Holsbeeck L et al (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572–586

    Article  PubMed  CAS  Google Scholar 

  • Lau WY, Ho S, Leung WT, Chan M, Lee WY, Johnson PJ (2001) What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres? Hepatogastroenterology 48:338–340

    PubMed  CAS  Google Scholar 

  • Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237–1248

    Article  PubMed  CAS  Google Scholar 

  • Leung TW, Lau WY, Ho SK et al (1995) Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33:919–924

    Article  PubMed  CAS  Google Scholar 

  • Lewandowski RJ, Thurston KG, Goin JE et al (2005) 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135–150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16:1641–1651

    PubMed  Google Scholar 

  • Liu DM, Salem R, Bui JT et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935

    PubMed  Google Scholar 

  • Liu MD, Uaje MB, Al-Ghazi MS et al (2004) Use of yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg 70:947–953

    PubMed  Google Scholar 

  • Murthy R, Kennedy AS, Coldwell D et al (2002) Technical aspects of TheraSphere (TS) infusion. J Vasc Interv Radiol 13:S2

    Google Scholar 

  • Murthy R, Brown DB, Salem R et al (2007) Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553–561; quiz 562

    Article  PubMed  Google Scholar 

  • Popperl G, Helmberger T, Munzing W, Schmid R, Jacobs TF, Tatsch K (2005) Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. Cancer Biother Radiopharm 20:200–208

    Article  PubMed  Google Scholar 

  • Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278

    Article  PubMed  Google Scholar 

  • Salem R, Lewandowski RJ, Atassi B et al (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639

    PubMed  Google Scholar 

  • Steel J, Baum A, Carr B (2004) Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere). Psychooncology 13:73–79

    Article  PubMed  Google Scholar 

  • Stefanovic L, Nikolic V, Obradovic M et al (2001) 131-I-lipiodol in therapy of liver carcinoma-methods and case report. Med Pregl 54:387–390

    PubMed  CAS  Google Scholar 

  • Stubbs RS, O’Brien I, Correia MM (2006) Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg 76:696–703

    Article  PubMed  Google Scholar 

  • Tateishi R, Yoshida H, Shiina S et al (2005) Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 54:419–425

    Article  PubMed  CAS  Google Scholar 

  • Van Hazel G, Blackwell A, Anderson J et al (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85

    Article  PubMed  CAS  Google Scholar 

  • Varela M, Sala M, Llovet JM, Bruix J (2003) Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma. Aliment Pharmacol Ther 17[Suppl 2]:98–102

    Article  PubMed  Google Scholar 

  • Wollner I, Knutsen C, Smith P et al (1988) Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 61:1336–1344

    Article  PubMed  CAS  Google Scholar 

  • Wong CY, Salem R, Qing F et al (2004) Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med 45:1892–1897

    PubMed  CAS  Google Scholar 

  • Wong JY, Shibata S, Williams LE et al (2003) A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer. Clin Cancer Res 9:5842–5852

    PubMed  CAS  Google Scholar 

  • Yorke ED, Jackson A, Fox RA, Wessels BW, Gray BN (1999) Can current models explain the lack of liver complications in Y-90 microsphere therapy? Clin Cancer Res 5:3024s–3030s

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Radiology and Nuclear Medicine, Klinikum Bogenhausen, Academic Teaching Hospital of the Technical University Munich, Engelschalkinger Strasse 77, 81925, Munich, Germany

    Thomas K. Helmberger MD (Professor)

Authors
  1. Thomas K. Helmberger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute for Diagnostic and Interventional Radiology University Hospital, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    Thomas J. Vogl MD (Professor) & Martin G. Mack MD (PD) (Professor) &  (PD)

  2. Department of Diagnostic and Interventional Radiology and Nuclear Medicine Klinikum Bogenhausen, Academic Teaching, Hospital of the Technical University Munich, Engelschalkingerstrasse 77, 81925, Munich, Germany

    Thomas K. Helmberger MD (Professor) (Professor)

  3. Department of Clinical Radiology University Hospitals — Grosshadern and Innenstadt, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Maximilian F. Reiser MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Helmberger, T.K. (2008). Selective Internal Radiation Therapy. In: Vogl, T.J., Helmberger, T.K., Mack, M.G., Reiser, M.F. (eds) Percutaneous Tumor Ablation in Medical Radiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68250-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68250-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22518-8

  • Online ISBN: 978-3-540-68250-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation